Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 6/2024

11-05-2024 | Atopic Dermatitis | Review

The role of the environment in allergic skin disease

Authors: Khushnood Faraz, Mason Seely, Anne L. Marano

Published in: Current Allergy and Asthma Reports | Issue 6/2024

Login to get access

Abstract

Purpose of Review

This paper explores how environmental factors influence allergic skin diseases, including atopic dermatitis (AD), contact dermatitis (CD), urticaria, angioedema, and reactions to drugs and insect bites.

Recent Findings

Research indicates a significant impact of environmental elements on allergic skin diseases. High air pollution levels exacerbate symptoms, while climate change contributes to increased skin barrier dysfunction, particularly affecting AD. Allergen prevalence is influenced by climate and pollution. Irritants, like those in detergents and cosmetics, play a major role in CD. Plants also contribute, causing various skin reactions.

Summary

Understanding the interplay between environmental factors and allergic skin diseases is crucial for effective management. Physicians must address these factors to support patient well-being and promote skin health amidst environmental changes.
Literature
1.
2.
3.
Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):209–13.PubMedCrossRef
4.
Bosma AL, et al. Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics. J Eur Acad Dermatol Venereol. 2022;36(6):807–19.PubMedPubMedCentralCrossRef
5.
Elias PM, Steinhoff M. “Outside-to-inside” (and now back to “outside”) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008;128(5):1067–70.PubMedPubMedCentralCrossRef
6.
Cork M, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–9.PubMedCrossRef
7.
• Paller AS, et al. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2022;400(10356):908–19.PubMedCrossRef
8.
• Blauvelt A, et al. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2021;157(9):1047–55.PubMedPubMedCentralCrossRef
9.
Mikhaylov D, et al. Oral Janus kinase inhibitors for atopic dermatitis. Ann Allergy Asthma Immunol. 2023;130(5):577–92.PubMedCrossRef
10.
11.
Diepgen TL, et al. Prevalence of contact allergy in the general population in different European regions. Br J Dermatol. 2016;174(2):319–29.PubMedCrossRef
12.
Alinaghi F, et al. Prevalence of contact allergy in the general population: A systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77–85.PubMedCrossRef
13.
Li Y, Li L. Contact Dermatitis: Classifications and Management. Clin Rev Allergy Immunol. 2021;61(3):245–81.PubMedCrossRef
14.
Coffin SL, Turrentine JE, Cruz PD Jr. Photodermatitis for the Allergist. Curr Allergy Asthma Rep. 2017;17(6):36.PubMedCrossRef
15.
16.
Zuberbier T, et al. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol. 2010;35(8):869–73.PubMedCrossRef
17.
18.
Church MK, et al. The role and relevance of mast cells in urticaria. Immunol Rev. 2018;282(1):232–47.PubMedCrossRef
19.
Zuberbier T, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734–66.PubMedCrossRef
20.
Weller K, et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J Eur Acad Dermatol Venereol. 2022;36(1):91–9.PubMedCrossRef
21.
Gonçalo M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226–36.PubMedCrossRef
22.
Türk M, et al. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers. J Allergy Clin Immunol Pract. 2020;8(1):113–24.PubMedCrossRef
23.
24.
Zalewska-Janowska A, Spiewak R, Kowalski ML. Cutaneous Manifestation of Drug Allergy and Hypersensitivity. Immunol Allergy Clin North Am. 2017;37(1):165–81.PubMedCrossRef
25.
Naldi L, Crotti S. Epidemiology of cutaneous drug-induced reactions. G Ital Dermatol Venereol. 2014;149(2):207–18.PubMed
26.
27.
Blumenthal KG, Ziegler JB. Hypersensitivity Reactions, Dietary Supplements, and the Importance of the Case Report. J Allergy Clin Immunol Pract. 2016;4(1):177–8.PubMedCrossRef
28.
Cohen PA. Assessing supplement safety—the FDA’s controversial proposal. N Engl J Med. 2012;366(5):389–91.PubMedCrossRef
29.
Teresa Ventura M, et al. Hypersensitivity reactions to complementary and alternative medicine products. Curr Pharm Des. 2006;12(26):3393–9.CrossRef
30.
Abrams EM, Golden DBK. Approach to Patients with Stinging Insect Allergy. Med Clin North Am. 2020;104(1):129–43.PubMedCrossRef
31.
Golden DB, et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28–54.PubMedCrossRef
32.
33.
Simons FER. Anaphylaxis. J Aller Clin Immunol. 2010;125(Supplement 2):S161–81.CrossRef
34.
35.
36.
Elston DM. Bites and stings. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Elsevier; 2018. p. 1516–35.
37.
38.
• Li A, et al. Associations between air pollution, climate factors and outpatient visits for eczema in West China Hospital, Chengdu, south-western China: a time series analysis. J Eur Acad Dermatol Venereol. 2018;32(3):486–94.PubMedCrossRef
39.
Pesce G, et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2015;29(6):1180–7.PubMedCrossRef
40.
Belugina IN, et al. Outdoor environment, ozone, radionuclide-associated aerosols and incidences of infantile eczema in Minsk. Belarus J Eur Acad Dermatol Venereol. 2018;32(11):1977–85.PubMedCrossRef
41.
Kim YM, et al. Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea. PLoS ONE. 2017;12(4): e0175229.PubMedPubMedCentralCrossRef
42.
Kim YM, et al. The effects of particulate matter on atopic dermatitis symptoms are influenced by weather type: Application of spatial synoptic classification (SSC). Int J Hyg Environ Health. 2018;221(5):823–9.PubMedCrossRef
43.
Cecchi L, D’Amato G, Annesi-Maesano I. External exposome and allergic respiratory and skin diseases. J Allergy Clin Immunol. 2018;141(3):846–57.PubMedCrossRef
44.
Belzer A, Parker ER. Climate Change, Skin Health, and Dermatologic Disease: A Guide for the Dermatologist. Am J Clin Dermatol. 2023;24(4):577–93.PubMedCrossRef
45.
Andersen LK, et al. Climate change and skin disease: a review of the English-language literature. Int J Dermatol. 2012;51(6):656–61.PubMedCrossRef
46.
St Leger RJ. Insects and their pathogens in a changing climate. J Invertebr Pathol. 2021;184: 107644.PubMedCrossRef
47.
Kuo IH, et al. The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol. 2013;131(2):266–78.PubMedCrossRef
48.
Celebi Sözener Z, et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145(6):1517–28.PubMedCrossRef
49.
50.
Bains SN, Nash P, Fonacier L. Irritant Contact Dermatitis. Clin Rev Allergy Immunol. 2019;56(1):99–109.PubMedCrossRef
51.
Seyfarth F, et al. Dry skin, barrier function, and irritant contact dermatitis in the elderly. Clin Dermatol. 2011;29(1):31–6.PubMedCrossRef
52.
Zhai H, Maibach HI. Skin occlusion and irritant and allergic contact dermatitis: an overview. Contact Dermatitis: Review Article. 2001;44(4):201–6.CrossRef
53.
Uter W, Gefeller O, Schwanitz HJ. An epidemiological study of the influence of season (cold and dry air) on the occurrence of irritant skin changes of the hands. Br J Dermatol. 1998;138(2):266–72.PubMedCrossRef
54.
Fluhr J, et al. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol. 2005;153(1):125–31.PubMedCrossRef
55.
McGovern TW. Dermatoses due to plants. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. 4th ed. Elsevier; 2018. p. 286–303.
56.
Williford PM, Sheretz EF. Poison ivy dermatitis. Nuances in treatment Arch Fam Med. 1994;3(2):184–8.PubMedCrossRef
57.
Bousquet J, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18–24.PubMedCrossRef
58.
Nixon RL, et al. Allergic contact dermatitis. In: Bolognia JL, Schaffer JV, Cerroni L, editors., et al., Dermatology. 4th ed. Elsevier; 2018. p. 242–61.
59.
DeKoven JG, et al. North american contact dermatitis group patch test results 2013–2014. Dermatitis. 2017;28(1):33–46.PubMedCrossRef
60.
Zug KA, et al. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.PubMedCrossRef
61.
Jacob SE, Admani S. iPad–increasing nickel exposure in children. Pediatrics. 2014;134(2):e580–2.PubMedCrossRef
62.
Boyapati A, et al. Allergic contact dermatitis to methylisothiazolinone: exposure from baby wipes causing hand dermatitis. Australas J Dermatol. 2013;54(4):264–7.PubMedCrossRef
63.
Scheinman PL. The foul side of fragrance-free products: what every clinician should know about managing patients with fragrance allergy. J Am Acad Dermatol. 1999;41(6):1020–4.PubMedCrossRef
64.
Metadata
Title
The role of the environment in allergic skin disease
Authors
Khushnood Faraz
Mason Seely
Anne L. Marano
Publication date
11-05-2024
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 6/2024
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-024-01147-9